Chester County News and Community Website
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) said it will release financial results for the fiscal fourth quarter ended December 31, 2025, before the New York Stock Exchange opens …
Vishay Sets Feb. 4 Earnings Call as Investors Eye Q4 Results Read More
EXTON, PA — Innovative Solutions & Support Inc., operating as Innovative Aerosystems (NASDAQ: ISSC), said it will report fourth-quarter and full-year 2025 financial results before the market opens on Thursday, …
Innovative Aerosystems Sets Date to Reveal Results as Aerospace Demand Builds Read More
VALLEY FORGE, PA — UGI Corporation (NYSE: UGI) reported a sharp rise in annual earnings and outlined a stronger long-term growth profile as the diversified energy company capped fiscal 2025 …
UGI Posts Record Earnings, Lifts Long-Term Growth Targets in 2026 Outlook Read More
WEST CHESTER, PA — Verrica Pharmaceuticals (Nasdaq: VRCA) raised approximately $50 million through a private investment in public equity, a move the company said will retire its debt facility, strengthen …
Verrica’s $50 Million PIPE Deal Sparks Big Questions About Its Next Growth Phase Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported third-quarter results that highlight accelerating commercial traction for its lead product, YCANTH®, alongside major regulatory and clinical milestones that broaden …
Verrica Posts Strong Q3 as YCANTH Momentum Builds and Late-Stage Pipeline Advances Read More
WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) reported the strongest quarter in its history, delivering explosive revenue growth and transformative gains tied to its Ethereum-first strategy. The company’s third-quarter results …
BTCS Rockets to Record Revenue as Ethereum Strategy Powers a Breakout Quarter Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported continued revenue growth and operational progress in the third quarter of 2025, supported by a strengthened leadership team, expanded sales infrastructure, …
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) reported third-quarter 2025 financial results and detailed a series of clinical, operational, and intellectual-property developments that the company says position its lead …
Annovis Rallies Around Phase 3 Alzheimer’s Push as New Data Signals Disease-Modifying Promise Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) reported third-quarter results and detailed an intensifying slate of clinical milestones as its QTORIN platform advances across four rare dermatologic diseases — …
Palvella Races Toward Key 2026 Readouts as Rare-Disease Pipeline Expands Rapidly Read More
WAYNE, PA — Trinseo (NYSE: TSE) reported another challenging quarter as soft global demand, pricing pressure in Europe, and lower equity income weighed heavily on results, pushing the specialty materials …
Trinseo’s Deeper Loss Spurs Aggressive Cuts as Demand Weakens Again Read More